Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/24282| Title: | A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Antimetabolites, Antineoplastic/administration & dosage/adverse effects,Antineoplastic Combined Chemotherapy Protocols/*administration & dosage/adverse,effects,Brain Neoplasms/*drug therapy/pathology/*radiotherapy/surgery,Bromodeoxyuridine/administration & dosage/adverse effects,Cognition/drug effects/radiation effects,Combined Modality Therapy,Disease Progression,Disease-Free Survival,Female,Glioblastoma/*drug therapy/pathology/*radiotherapy/surgery,Humans,Lomustine/administration & dosage/adverse effects,Male,Middle Aged,Procarbazine/administration & dosage/adverse effects,Radiation-Sensitizing Agents/*administration & dosage/adverse effects,Reoperation,Vincristine/administration & dosage/adverse effects |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/24282 |
| ISSN: | 0360-3016 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/10477016 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
